| # | Drug | Count |
|---|---|---|
| 0 | CERITINIB | 90 |
| 1 | CARBOPLATIN | 46 |
| 2 | CRIZOTINIB | 25 |
| 3 | PACLITAXEL | 24 |
| 4 | PEMETREXED DISODIUM | 23 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 19 |
| 6 | PEMBROLIZUMAB | 19 |
| 7 | PEMETREXED | 19 |
| 8 | METHOTREXATE SODIUM | 14 |
| 9 | OMEPRAZOLE MAGNESIUM | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CERITINIB | 90 | 0.0378 |
| 1 | CAPMATINIB | 6 | 0.0025 |
| 2 | DATOPOTAMAB DERUXTECAN | 2 | 0.0023 |
| 3 | SOTORASIB | 7 | 0.0020 |
| 4 | CRIZOTINIB | 25 | 0.0020 |
| 5 | BRIGATINIB | 6 | 0.0016 |
| 6 | ERLOTINIB HYDROCHLORIDE | 13 | 0.0010 |
| 7 | LORLATINIB | 5 | 0.0007 |
| 8 | RAMUCIRUMAB | 4 | 0.0006 |
| 9 | PEMETREXED DISODIUM | 23 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 133 |
| 1 | Platinum-based Drug [EPC] | 56 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 32 |
| 3 | Microtubule Inhibitor [EPC] | 31 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 24 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 24 |
| 6 | Corticosteroid [EPC] | 22 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 22 |
| 8 | Benzodiazepine [EPC] | 18 |
| 9 | Proton Pump Inhibitor [EPC] | 16 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 1 | Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] | 1 | 0.0005 |
| 2 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 4 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 5 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 24 | 0.0002 |
| 7 | Kinase Inhibitor [EPC] | 133 | 0.0002 |
| 8 | Potassium-sparing Diuretic [EPC] | 3 | 0.0002 |
| 9 | Platinum-based Drug [EPC] | 56 | 0.0002 |